
Sosei announces $1.2bn R&D collaboration with Abbvie
The strategic collaboration leverages Sosei Heptares’ StaR technology and structure-based drug design platform and AbbVie’s extensive...

Swedish SOBI awarded rights to market Zynlonta from ADC therapeutics
ADC therapeutics has signed a deal giving Swedish Orphan Biovitrum AB (Sobi) rights to develop and market Zynlonta in hematologic and solid tumor...

Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac
Aurobac Therapeutics SAS goal is to create next-generation antimicrobials and diagnostics to fight Antimicrobial Resistance (AMR). Decades ago, drug...

Unilever launches $120m venture with Genomatica
US biotechnology company Genomatica is a producer of sustainable materials derived from plant- or waste-based feedstocks instead of fossil fuels....

Lonza invests CHF500m in Large-Scale Facility in Stein (CH)
Since establishing drug product development and manufacturing services in 2016, Lonza has expanded its clinical drug product offering...

French Ipsen falls after Epizyme take-over announcement
Even if Ipsen succeeds in halving the losses at Epizyme Inc, this would reduce the group's profit by nine percent by 2024, Credit Suisse analysts...

Roche obtains special authorisation for bispecific antibody
Roches new developed immunotherapy is based on a bispecific antibody, which targets B-lymphocyte antigen CD20 and the CD3-T-cell receptor at the...